Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening

November 12, 2020 Leave a comment 1,348 Views

Lexogen GmbH, a Vienna-based market leader in Next-Generation Sequencing (NGS) and transcriptomics announced today the launch of a pioneering ultra-high-throughput SARS-CoV-2 test that will allow for the first time a true mass screening of the whole population. This test allows ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: public health

Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening

Learning to predict RNA sequence expressions from whole slide images

CRIC-seq – global profiling of in-situ RNA–RNA contacts associated with a specific RNA-binding protein

Novel machine-learning algorithm creates atlas of cancer with potential as universal diagnostic platform

Long noncoding RNA profiling may be effective for stratification in pediatric AML

spSeudoMap – cell type mapping of spatial transcriptomics using unmatched single-cell RNA-seq data

SoCube – an innovative end-to-end doublet detection algorithm for analyzing scRNA-seq data

Quantabio adds powerful bead booster chemistry to ultra-fast sparQ RNA-Seq HMR kit